Reliable and Affordable R&D Service for Global Life Science
We Are No. 1 in China for a Reason

About Venturepharm

　　■　No.1 status of New Drug Applications in China for 8 years 　- Statistics from SFDA
　　■　One of the five most promising companies in china 　　　　- Fortune US
　　■　Entrepreneur and innovation Award 2004 　　 　　　　　　- British Chamber UK
　　■　Best CRO in Asia; Competitive Strategy Award 2007　 　　- Frost & Sullivan
　　■　Winner of 2004 Ten Best Management Elites　　 　 　- Government Organization, China
　　■　Best Run Join Venture 2003　　　　　　　　　　　　 　　- Association of JV China

Venturepharm Asia is a global life science leader with a strategic focus on venture capital, merchant banking, CRO, CMO, CSO, compound partnering, and royalty sharing. The group develops an innovative full service plus model to position itself strongly in the life science industry. Currently Venturepharm Asia has more than two thousand employees.

Two flagships from the group are public trade companies listed in HK and US:

　　■　Venturepharm Lab.(HKSE :8225)　www.venturepharm.com
　　 -The First Chinese Research-driven Pharmaceutical Service Company Listed Overseas

　　■　CBI Group (NASDAQ: CBTE)　www.cbi-biotech.com
　　 -The Global Leader in Drug Discovery & Service

2007-2008 Partners

*A selectionof our partners recently publicly disclosed

VPSCRO Number 1 CRO for Global Trials in China

www.vpscro.com

A Competitive Differentiation Setting the Tone for Your Success

- The largest and only public CRO in China
- Leader in Oncology, CNS, Cardiovascular, Diabetic, GI, Respiratory, and Allergy
- No.1 regulatory affair team with a proved record of over 500 successful project applications with SFDA
- The only integrated CRO with central analytical lab, phase I lab, animal lab, and the largest data management team
- Well Developed Client Base: 36 of the top 50 Pharma companies in China, over 20 Global Biotech/Pharma companies

VPRA -ChinaRegulatory Affairs Express
No. 1 Regulatory Services provider for 8 years
500 successful cases with SFDA
Over 10 ANDA, DMF applications with FDA
　　- Regulatory Affairs Consulting

Venturepharm (Asia) _Global footprint
Commonwealth Biotechnologies Inc. (CBI)　 www.cbi-biotech.com

CBI (Richmond, VA, USA) acts as an essential extension of Venturepharm (Asia) in North America, and provides world class biological services for drug discovery and pre-clinical support

• Physicochemical analysis
• Immunology
• Microbiology
• Bioinformatics
• Full Regulatory Support under FDA GLP Guidelines 21 CFR 58

	www.mimotopes.com
	Mimotopes (Australia), another Venturepharm family member, provides high quality research-grade peptide products and applications for drug discovery
World class peptide synthesis capability，High throughput capabilities Proprietary SynPhaseTM technology，Nearly 2 decades of experience

	www.triposdiscoveryresearch.com
Exelgen (UK) utilizes proprietary computational technology and medicinal chemistry expertise in the discovery and optimization of pre-clinical candidates Medicinal Chemistry Design Library Synthesis Biological Screening Analysis and Production